The DIA 46th Annual Meeting will take place June 13-17, 2010 in Washington, DC. The DIA Annual Meeting is the premier event to attend each year by professionals from the biopharmaceutical and related sectors, as well as regulatory professionals from around the world. There is no other event of its kind that can rival the breadth and depth of experience that this meeting delivers. With 25 content areas and 350 sessions, the presentations are geared to all experience levels and functional areas.
“Dr. Hamburg is an inspiring public health leader with broad experience in public health and medicine, infectious disease, bioterrorism and emergency preparedness,” says DIA Worldwide Executive Director Paul Pomerantz. “We are delighted to have her open our 46th Annual Meeting in Washington DC—home of FDA and the global center of public health policy.”
Dr. Margaret Hamburg was nominated by President Barack Obama for the FDA Commissioner on March 25, 2009 and on May 18, 2009 became the 21st Food and Drug Commissioner. She previously served as the assistant secretary for planning and evaluation in the U.S. Department of Health and Human Services under President Clinton, and as the assistant director of the National Institute of Allergy and Infectious Diseases of the National Institutes of Health.
In 2001, Dr. Hamburg became Vice President for Biological Programs at the Nuclear Threat Initiative, a foundation dedicated to reducing the threat to public safety from nuclear, chemical, and biological weapons. In that position, she advocated for broad reforms in public health infrastructure and policy, from local health departments to the national agency, in order to meet the dangers of modern bioterrorism as well as the threats of naturally occurring infectious diseases such as pandemic flu. Dr. Hamburg is only the second woman to serve as FDA commissioner in the agency's 100-year history.
Register for the DIA 46th Annual Meeting.
“Dr. Hamburg is an inspiring public health leader with broad experience in public health and medicine, infectious disease, bioterrorism and emergency preparedness,” says DIA Worldwide Executive Director Paul Pomerantz. “We are delighted to have her open our 46th Annual Meeting in Washington DC—home of FDA and the global center of public health policy.”
Dr. Margaret Hamburg was nominated by President Barack Obama for the FDA Commissioner on March 25, 2009 and on May 18, 2009 became the 21st Food and Drug Commissioner. She previously served as the assistant secretary for planning and evaluation in the U.S. Department of Health and Human Services under President Clinton, and as the assistant director of the National Institute of Allergy and Infectious Diseases of the National Institutes of Health.
In 2001, Dr. Hamburg became Vice President for Biological Programs at the Nuclear Threat Initiative, a foundation dedicated to reducing the threat to public safety from nuclear, chemical, and biological weapons. In that position, she advocated for broad reforms in public health infrastructure and policy, from local health departments to the national agency, in order to meet the dangers of modern bioterrorism as well as the threats of naturally occurring infectious diseases such as pandemic flu. Dr. Hamburg is only the second woman to serve as FDA commissioner in the agency's 100-year history.
Register for the DIA 46th Annual Meeting.
Companies in this article
